SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-042997
Filing Date
2024-05-14
Accepted
2024-05-14 16:45:38
Documents
81
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0205497-10q_allarity.htm   iXBRL 10-Q 884163
2 CONSULTING AGREEMENT (JAMES G. CULLEM) ea020549701ex10-6_allarity.htm EX-10.6 23898
3 CONFIDENTIAL SETTLEMENT AGREEMENT AND GENERAL RELEASE (JAMES G. CULLEM) ea020549701ex10-7_allarity.htm EX-10.7 59609
4 CERTIFICATION ea020549701ex31-1_allarity.htm EX-31.1 16991
5 CERTIFICATION ea020549701ex31-2_allarity.htm EX-31.2 15042
6 CERTIFICATION ea020549701ex32-1_allarity.htm EX-32.1 6190
7 CERTIFICATION ea020549701ex32-2_allarity.htm EX-32.2 6211
  Complete submission text file 0001213900-24-042997.txt   5901690

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE allr-20240331.xsd EX-101.SCH 65706
9 XBRL CALCULATION FILE allr-20240331_cal.xml EX-101.CAL 38072
10 XBRL DEFINITION FILE allr-20240331_def.xml EX-101.DEF 295528
11 XBRL LABEL FILE allr-20240331_lab.xml EX-101.LAB 513234
12 XBRL PRESENTATION FILE allr-20240331_pre.xml EX-101.PRE 295787
85 EXTRACTED XBRL INSTANCE DOCUMENT ea0205497-10q_allarity_htm.xml XML 613724
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41160 | Film No.: 24945240
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)